Chrome Extension
WeChat Mini Program
Use on ChatGLM

727 Topline Safety and Efficacy Update of SUPLEXA-101, a First-in-human, Single Agent Study of SUPLEXA Therapeutic Cells in 28 Patients with Metastatic Solid Tumours

Journal for ImmunoTherapy of Cancer(2023)

Cited 0|Views36
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined